Related references
Note: Only part of the references are listed.Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
C. H. Chung et al.
ANNALS OF ONCOLOGY (2010)
Antitumor 1-nitroacridine derivative C-1748, induces apoptosis, necrosis or senescence in human colon carcinoma HCT8 and HT29 cells
Ewa Augustin et al.
BIOCHEMICAL PHARMACOLOGY (2010)
A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group Trial
Stacy Moulder et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate
Bin Zhang et al.
CANCER CELL (2010)
Acquired Resistance of Non-Small Cell Lung Cancer Cells to MET Kinase Inhibition Is Mediated by a Switch to Epidermal Growth Factor Receptor Dependency
Ultan McDermott et al.
CANCER RESEARCH (2010)
Cancer systems biology: a network modeling perspective
Pamela K. Kreeger et al.
CARCINOGENESIS (2010)
Secreted protein acidic and rich in cysteine-induced cellular senescence in colorectal cancers in response to irinotecan is mediated by P53
Justin M. Chan et al.
CARCINOGENESIS (2010)
Chk1 inhibition after replicative stress activates a double strand break response mediated by ATM and DNA-dependent protein kinase
Samuel McNeely et al.
CELL CYCLE (2010)
Death Receptor Agonists as a Targeted Therapy for Cancer
Jeffrey Wiezorek et al.
CLINICAL CANCER RESEARCH (2010)
A Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced Malignancies
D. Ross Camidge et al.
CLINICAL CANCER RESEARCH (2010)
New Insights into Checkpoint Kinase 1 in the DNA Damage Response Signaling Network
Yun Dai et al.
CLINICAL CANCER RESEARCH (2010)
The Current Status and Future of Multiple Myeloma in the Clinic
Sundar Jagannath et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2010)
DAP1, a Novel Substrate of mTOR, Negatively Regulates Autophagy
Itay Koren et al.
CURRENT BIOLOGY (2010)
Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells
Sanjeevani Arora et al.
DNA REPAIR (2010)
Autophagy and tumorigenesis
Nan Chen et al.
FEBS LETTERS (2010)
Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study
Koen De Geest et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase I and Pharmacologic Study of SNS-032, a Potent and Selective Cdk2, 7, and 9 Inhibitor, in Patients With Advanced Chronic Lymphocytic Leukemia and Multiple Myeloma
Wei-Gang Tong et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase I Dose-Escalation Study of Recombinant Human Apo2L/TRAIL, a Dual Proapoptotic Receptor Agonist, in Patients With Advanced Cancer
Roy S. Herbst et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval
Peter C. Fong et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Recent advances in gastrointestinal oncology - updates and insights from the 2009 annual meeting of the American Society of Clinical Oncology
Milind Javle et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2010)
Cancer-Associated Fibroblasts Derived from EGFR-TKI-Resistant Tumors Reverse EGFR Pathway Inhibition by EGFR-TKIs
Sheldon R. Mink et al.
MOLECULAR CANCER RESEARCH (2010)
The transcriptional network for mesenchymal transformation of brain tumours
Maria Stella Carro et al.
NATURE (2010)
Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
Hagop Kantarjian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
Giuseppe Saglio et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
p53-and p21-dependent premature APC/C-Cdh1 activation in G2 is part of the long-term response to genotoxic stress
L. Wiebusch et al.
ONCOGENE (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
Gemcitabine Induces the VMP1-Mediated Autophagy Pathway to Promote Apoptotic Death in Human Pancreatic Cancer Cells
Romina Pardo et al.
PANCREATOLOGY (2010)
A Phase II Trial of the Epothilone B Analog Ixabepilone (BMS-247550) in Patients with Metastatic Melanoma
Patrick A. Ott et al.
PLOS ONE (2010)
Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
Christine Gjerdrum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
X-ray structure and mechanism of RNA polymerase II stalled at an antineoplastic monofunctional platinum-DNA adduct
Dong Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A Global Protein Kinase and Phosphatase Interaction Network in Yeast
Ashton Breitkreutz et al.
SCIENCE (2010)
The Genetic Landscape of a Cell
Michael Costanzo et al.
SCIENCE (2010)
The Role of the Kinases RIP1 and RIP3 in TNF-Induced Necrosis
Peter Vandenabeele et al.
SCIENCE SIGNALING (2010)
Cancer stem cells in solid tumors
Patrick C. Hermann et al.
SEMINARS IN CANCER BIOLOGY (2010)
Integrating and annotating the interactome using the MiMI plugin for cytoscape
Jing Gao et al.
BIOINFORMATICS (2009)
Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations
Martin C. Mueller et al.
BLOOD (2009)
Bortezomib induces canonical nuclear factor-κB activation in multiple myeloma cells
Teru Hideshima et al.
BLOOD (2009)
Epidermal growth factor receptor cooperates with Src family kinases in acquired resistance to cetuximab
Deric L. Wheeler et al.
CANCER BIOLOGY & THERAPY (2009)
Moderate Increase in Mdr1a/1b Expression Causes In vivo Resistance to Doxorubicin in a Mouse Model for Hereditary Breast Cancer
Marina Pajic et al.
CANCER RESEARCH (2009)
Detection of Treatment-Induced Changes in Signaling Pathways in Gastrointestinal Stromal Tumors Using Transcriptomic Data
Michael F. Ochs et al.
CANCER RESEARCH (2009)
A Vascular Normalization Index as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
A. Gregory Sorensen et al.
CANCER RESEARCH (2009)
Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells
Claudia Scholl et al.
CELL (2009)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
Autophagy Suppresses Tumorigenesis through Elimination of p62
Robin Mathew et al.
CELL (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
BubR1 is an effector of multiple mitotic kinases that specifies kinetochore: Microtubule attachments and checkpoint
Haomin Huang et al.
CELL CYCLE (2009)
Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors
Ana M. Mendes-Pereira et al.
EMBO MOLECULAR MEDICINE (2009)
Mechanisms of tumor resistance to EGFR-targeted therapies
Elizabeth A. Hopper-Borge et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
William Y. Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
5-Year Survival in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia in a Randomized, Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen
Susan O'Brien et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Initial Safety Report of NSABP C-08: A Randomized Phase III Study of Modified FOLFOX6 With or Without Bevacizumab for the Adjuvant Treatment of Patients With Stage II or III Colon Cancer
Carmen J. Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Validation of the Royal Marsden Hospital Prognostic Index in Advanced Esophagogastric Cancer Using Individual Patient Data From the REAL 2 Study
Ian Chau et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The Epithelial-to-Mesenchymal Transition and Cancer Stem Cells: A Coalition Against Cancer Therapies
Brett G. Hollier et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2009)
Bortezomib Plus Gemcitabine/Carboplatin as First-Line Treatment of Advanced Non-small Cell Lung Cancer A Phase II Southwest Oncology Group Study (S0339)
Angela M. Davies et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer
David O. Azorsa et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Gadd45-α and Gadd45-γ utilize p38 and JNK signaling pathways to induce cell cycle G2/M arrest in Hep-G2 hepatoma cells
Na Zhu et al.
MOLECULAR BIOLOGY REPORTS (2009)
Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma
Vanessa Milano et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance
Edith A. Perez
MOLECULAR CANCER THERAPEUTICS (2009)
Determinants for the efficiency of anticancer drugs targeting either Aurora-A or Aurora-B kinases in human colon carcinoma cells
Phillip Kaestner et al.
MOLECULAR CANCER THERAPEUTICS (2009)
A Small Molecule Inhibitor of Inducible Heat Shock Protein 70
J. I-Ju Leu et al.
MOLECULAR CELL (2009)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie et al.
NATURE (2009)
Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages
Gabriela Molina et al.
NATURE CHEMICAL BIOLOGY (2009)
Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity
Esti Yeger-Lotem et al.
NATURE GENETICS (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The ERCC1/XPF endonuclease is required for completion of homologous recombination at DNA replication forks stalled by inter-strand cross-links
Ali Z. Al-Minawi et al.
NUCLEIC ACIDS RESEARCH (2009)
Fanconi anemia deficiency stimulates HPV-associated hyperplastic growth in organotypic epithelial raft culture
E. E. Hoskins et al.
ONCOGENE (2009)
Autophagy Facilitates the Development of Breast Cancer Resistance to the Anti-HER2 Monoclonal Antibody Trastuzumab
Alejandro Vazquez-Martin et al.
PLOS ONE (2009)
Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer
Marisa G. Ponzo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
Jihye Yun et al.
SCIENCE (2009)
Cell Signaling in Space and Time: Where Proteins Come Together and When They're Apart
John D. Scott et al.
SCIENCE (2009)
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Kornelia Polyak et al.
NATURE REVIEWS CANCER (2009)
Short interfering RNA directed against TWIST, a novel zinc finger transcription factor, increases A549 cell sensitivity to cisplatin via MAPK/mitochondrial pathway
Wen-Lei Zhuo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Characterization of a stem cell population in lung cancer A549 cells
Ji-Min Sung et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Identifying gene-disease associations using centrality on a literature mined gene-interaction network
Arzucan Oezguer et al.
BIOINFORMATICS (2008)
Drug transporters: Recent advances concerning BCRP and tyrosine kinase inhibitors
C. Lemos et al.
BRITISH JOURNAL OF CANCER (2008)
Transient Potent BCR-ABL Inhibition Is Sufficient to Commit Chronic Myeloid Leukemia Cells Irreversibly to Apoptosis
Neil P. Shah et al.
CANCER CELL (2008)
Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer
Elizabeth Iorns et al.
CANCER CELL (2008)
ABCG2 expression and side population abundance regulated by a transforming growth factor β-directed epithelial-mesenchymal transition
Liqun Yin et al.
CANCER RESEARCH (2008)
Chemotherapy Induces Tumor Clearance Independent of Apoptosis
Jennifer L. Guerriero et al.
CANCER RESEARCH (2008)
The MDM2 inhibitor nutlins as an innovative therapeutic tool for the treatment of haematological malignancies
Paola Secchiero et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers
Michele Sabbah et al.
DRUG RESISTANCE UPDATES (2008)
A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor
Nicholas C. Turner et al.
EMBO JOURNAL (2008)
Keeping checkpoint kinases in line: new selective inhibitors in clinical trials
Susan Ashwell et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Cancer stem cells and the ontogeny of lung cancer
Craig D. Peacock et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
Xiaoxian Li et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type mice
Serena Marchetti et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling
Ilaria Malanchi et al.
NATURE (2008)
Network pharmacology: the next paradigm in drug discovery
Andrew L. Hopkins
NATURE CHEMICAL BIOLOGY (2008)
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma
Jesus F. San Miguel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines
M. Kitagawa et al.
ONCOGENE (2008)
Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members
D. L. Wheeler et al.
ONCOGENE (2008)
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Sian Jones et al.
SCIENCE (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Systems Biology of Growth Factor-Induced Receptor Endocytosis
Yaara Zwang et al.
TRAFFIC (2008)
The role of efflux and uptake transporters in N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine (GW572016, Lapatinib) disposition and drug interactions
Joseph W. Polli et al.
DRUG METABOLISM AND DISPOSITION (2008)
ABCG2: structure, function and role in drug response
Orsolya Polgar et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Evolvable signaling networks of receptor tyrosine kinases: relevance of robustness to malignancy and to cancer therapy
Ido Amit et al.
MOLECULAR SYSTEMS BIOLOGY (2007)
Base excision DNA repair defect in Gadd45a-deficient cells
H. J. Jung et al.
ONCOGENE (2007)
Erlotinib (Tarceva, OSI-774) antagonizes ATP-bInding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance
Zhi Shi et al.
CANCER RESEARCH (2007)
Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins
Weidong Wang
NATURE REVIEWS GENETICS (2007)
Targeting the hedgehog pathway to mitigate treatment resistance
Yu-Jen Chen et al.
CELL CYCLE (2007)
Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression:: A phase III trial in non-small-cell lung cancer
Manuel Cobo et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers
Sendurai A. Mani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs
Charles Swanton et al.
CANCER CELL (2007)
Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia
Aparna Raval et al.
CELL (2007)
Autophagy suppresses tumor progression by limiting chromosomal instability
Robin Mathew et al.
GENES & DEVELOPMENT (2007)
Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses
Kate L. Jeffrey et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1
G. Ambrosini et al.
ONCOGENE (2007)
Synthetic lethal screen identification of chemosensitizer loci in cancer cells
Angelique W. Whitehurst et al.
NATURE (2007)
Bax and the mitochondrial permeability transition cooperate in the release of cytochrome c during endoplasmic reticulum-stress-induced apoptosis
D. Zhang et al.
CELL DEATH AND DIFFERENTIATION (2007)
Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel
George Z. Cheng et al.
CANCER RESEARCH (2007)
DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells
M. Katayama et al.
CELL DEATH AND DIFFERENTIATION (2007)
A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade™), in combination with paclitaxel and carboplatin in patients with advanced malignancies
Cynthia Ma et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Genetic screening for signal transduction in the era of network biology
Adam Friedman et al.
CELL (2007)
Identification and expansion of human colon-cancer-initiating cells
Lucia Ricci-Vitiani et al.
NATURE (2007)
Physiological and pharmacological functions of Mrp2, Mrp3 and Mrp4 as determined from recent studies on gene-disrupted mice
Gary D. Kruh et al.
CANCER AND METASTASIS REVIEWS (2007)
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia
Brian J. Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways
Minli Wang et al.
NUCLEIC ACIDS RESEARCH (2006)
Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions
Steven R. Bartz et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Targeting calmodulin in reversing multi drug resistance in cancer cells
Y. C. Mayur et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2006)
The bad guy cooperates with good cop p53: Bad is transcriptionally up-regulated by p53 and forms a bad/p53 complex at the mitochondria to induce apoptosis
Peng Jiang et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: The oblimersen melanoma study group
Agop Y. Bedikian et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Minimizing the risk of reporting false positives in large-scale RNAi screens
Christophe J. Echeverri et al.
NATURE METHODS (2006)
Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition
Nuala McCabe et al.
CANCER RESEARCH (2006)
Poly(ADP-ribose) polymerase-1 signaling to mitochondria in necrotic cell death requires RIP1/TRAF2-mediated JNK1 activation
Y Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
αE-catenin controls cerebral cortical size by regulating the hedgehog signaling pathway
WH Lien et al.
SCIENCE (2006)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
JA Bonner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Hematopoietic cells from Gadd45a- and Gadd45b-deficient mice are sensitized to genotoxic-stress-induced apoptosis
M Gupta et al.
ONCOGENE (2005)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of caspase-2
LK Nutt et al.
CELL (2005)
The focal adhesion scaffolding protein HEF1 regulates activation of the Aurora-A and Nek2 kinases at the centrosome
EN Pugacheva et al.
NATURE CELL BIOLOGY (2005)
The melanocyte differentiation program predisposes to metastasis after neoplastic transformation
PB Gupta et al.
NATURE GENETICS (2005)
Systematic yeast synthetic lethal and synthetic dosage lethal screens identify genes required for chromosome segregation
V Measday et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cooperation of the Cockayne syndrome group B protein and poly(ADP-ribose) polymerase 1 in the response to oxidative stress
T Thorslund et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance
JP MacKeigan et al.
NATURE CELL BIOLOGY (2005)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Genomics in breast cancer - therapeutic implications
PE Lonning et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
The role of autophagy in cancer development and response to therapy
Y Kondo et al.
NATURE REVIEWS CANCER (2005)
Identification and biochemical characterization of a Werner's syndrome protein complex with Ku70/80 and poly(ADP-ribose) polymerase-1
BM Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
CG Willett et al.
NATURE MEDICINE (2004)
Cell death: Critical control points
NN Danial et al.
CELL (2004)
Hydroxyurea arrests DNA replication by a mechanism that preserves basal dNTP pools
A Koç et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress
M Kajita et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Functional defects in the Fanconi anemia pathway in pancreatic cancer cells
MS Van der Heijden et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
DNA damage-induced activation of ATM and ATM-dependent signaling pathways
EU Kurz et al.
DNA REPAIR (2004)
Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining
M Audebert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
D Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Initiating cellular stress responses
CJ Bakkenist et al.
CELL (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe
M Castedo et al.
ONCOGENE (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The MRP family of drug efflux pumps
GD Kruh et al.
ONCOGENE (2003)
Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer
MS Tallman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Clinical update: proteasome inhibitors in solid tumors
HJ Lenz
CANCER TREATMENT REVIEWS (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Taxanes: Microtubule and Centrosome Targets, and Cell Cycle Dependent Mechanisms of Action
M. Abal et al.
CURRENT CANCER DRUG TARGETS (2003)
The role of ABC transporters in clinical practice
GD Leonard et al.
ONCOLOGIST (2003)
Epithelial-mesenchymal transitions in development and pathologies
JP Thiery
CURRENT OPINION IN CELL BIOLOGY (2003)
Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development
D Shook et al.
MECHANISMS OF DEVELOPMENT (2003)
Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids
GB Wisely et al.
STRUCTURE (2002)
Tumorigenesis -: RAF/RAS oncogenes and mismatch-repair status
H Rajagopalan et al.
NATURE (2002)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin
ZY Han et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A transcription factor regulatory circuit in differentiated pancreatic cells
SF Boj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
If not apoptosis, then what? - Treatment-induced senescence and mitotic catastrophe in tumor cells
IB Roninson et al.
DRUG RESISTANCE UPDATES (2001)
Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2
V Sudakin et al.
JOURNAL OF CELL BIOLOGY (2001)
Chemosensitization of pancreatic cancer by inhibition of the 26S proteasome
RJ Bold et al.
JOURNAL OF SURGICAL RESEARCH (2001)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Necrotic, rather than apoptotic, cell death caused by cytochrome P450-activated ifosfamide
P Karle et al.
CANCER GENE THERAPY (2001)
26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer
SA Shah et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2001)
Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer.
EA Stadtmauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
